Amgen Inc.

United States of America

Back to Profile

1-100 of 106 for Amgen Inc. Sort by
Query
Trademark
Canada - CIPO
Excluding Subsidiaries
Aggregations Reset Report
Date
2023 16
2022 5
2021 7
2020 8
2019 9
See more
NICE Class
05 - Pharmaceutical, veterinary and sanitary products 82
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services 14
41 - Education, entertainment, sporting and cultural services 13
35 - Advertising and business services 11
10 - Medical apparatus and instruments 8
See more
Status
Pending 27
Registered / In Force 79
Found results for  trademarks
  1     2        Next Page

1.

IMDYLLTRA

      
Application Number 228694300
Status Pending
Filing Date 2023-10-13
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations used for the treatment of lung, prostate and respiratory disorders

2.

BEMJENTYK

      
Application Number 229594400
Status Pending
Filing Date 2023-10-06
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of gastric and gastro-esophageal diseases, conditions or maladies; other pharmaceutical preparations.

3.

BEMTARJIK

      
Application Number 229594500
Status Pending
Filing Date 2023-10-06
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of gastric and gastro-esophageal diseases, conditions or maladies; other pharmaceutical preparations.

4.

BIMTUVIQ

      
Application Number 229594600
Status Pending
Filing Date 2023-10-06
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of gastric and gastro-esophageal diseases, conditions or maladies; other pharmaceutical preparations.

5.

WEZLANA

      
Application Number 229884400
Status Pending
Filing Date 2023-09-01
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure.

6.

LEYTEVU

      
Application Number 228114100
Status Pending
Filing Date 2023-08-07
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure.

7.

SKOJOY

      
Application Number 228773800
Status Pending
Filing Date 2023-08-07
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure.

8.

VICDELLIO

      
Application Number 227586700
Status Pending
Filing Date 2023-07-17
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations used for the treatment of lung, prostate and respiratory disorders.

9.

DD D

      
Application Number 227587100
Status Pending
Filing Date 2023-07-17
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations used for the treatment of lung, prostate and respiratory disorders.

10.

IMDELLTRA

      
Application Number 227728800
Status Pending
Filing Date 2023-07-17
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations used for the treatment of lung, prostate and respiratory disorders.

11.

VICDELLIO

      
Application Number 227586600
Status Pending
Filing Date 2023-07-17
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations used for the treatment of lung, prostate and respiratory disorders.

12.

GEOMETRIC SHAPES DESIGN

      
Application Number 227586900
Status Pending
Filing Date 2023-07-17
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations used for the treatment of lung, prostate and respiratory disorders.

13.

IMDELLTRA

      
Application Number 227728700
Status Pending
Filing Date 2023-07-17
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations used for the treatment of lung, prostate and respiratory disorders.

14.

CONFIPEN

      
Application Number 226010400
Status Pending
Filing Date 2023-04-25
Owner Amgen Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

(1) Injectors pre-filled with pharmaceutical preparations for treating cancer and immune diseases and conditions. (2) Injectors for medical purposes, namely, medical fluid injectors.

15.

VICDELLIO

      
Application Number 224813900
Status Pending
Filing Date 2023-03-27
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations used for the treatment of lung, prostate and respiratory disorders

16.

IMDELLTRA

      
Application Number 223505500
Status Pending
Filing Date 2023-01-24
Owner AMGEN INC. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations used for the treatment of lung, prostate and respiratory disorders

17.

PAVBLU

      
Application Number 221371800
Status Pending
Filing Date 2022-10-04
Owner AMGEN INC. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure

18.

WEZENLA

      
Application Number 220817900
Status Registered
Filing Date 2022-09-07
Registration Date 2024-02-12
Owner AMGEN INC. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure

19.

BEKEMV

      
Application Number 220415000
Status Pending
Filing Date 2022-08-15
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure

20.

PAVCUE

      
Application Number 221120600
Status Pending
Filing Date 2022-07-14
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Préparations pharmaceutiques pour la prévention et le traitement du système nerveux central, à savoir les infections du système nerveux central, les maladies du cerveau, les troubles du mouvement du système nerveux central, les troubles de la motilité oculaire, les maladies de la moelle épinière; préparations pharmaceutiques pour la prévention et le traitement de maladies immunologiques, à savoir des maladies auto-immunes, des syndromes de déficit immunitaire; préparations pharmaceutiques pour la prévention et le traitement des maladies cardiovasculaires; préparations pharmaceutiques pour la prévention et le traitement du diabète; préparations pharmaceutiques pour la prévention et le traitement des troubles métaboliques, à savoir le diabète, l'obésité, l'hyperlipidémie, la résistance à l'insuline, le syndrome métabolique; anti-inflammatoires; préparations pharmaceutiques pour la prévention et le traitement des troubles du système respiratoire; préparations pharmaceutiques pour la prévention et le traitement des troubles du système musculo-squelettique, à savoir les maladies du tissu conjonctif, les maladies des os, les maladies de la colonne vertébrale, les maux de dos, les fractures, les entorses, les blessures du cartilage; préparations pharmaceutiques pour la prévention et le traitement des maladies génito-urinaires, à savoir les maladies urologiques, l'infertilité, les maladies sexuellement transmissibles, les inflammations pelviennes; préparations pharmaceutiques utilisées en dermatologie, à savoir la dermatite, les maladies affectant la pigmentation de la peau, les maladies sexuellement transmissibles; préparations pharmaceutiques utilisées en oncologie; préparations pharmaceutiques utilisées en hématologie, à savoir pour le traitement des troubles sanguins; préparations pharmaceutiques utilisée pour la transplantation de tissus et d'organes; préparations pharmaceutiques utilisées en ophtalmologie; préparations pharmaceutiques utilisées en gastroentérologie; préparations pharmaceutiques pour la prévention et le traitement des troubles et des maladies oculaires; anti-infectieux, antibactériens, antiviraux, antibiotiques, antifongiques systémiques et topiques.

21.

TEZSPIRE

      
Application Number 217116000
Status Registered
Filing Date 2022-03-08
Registration Date 2023-09-13
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of respiratory diseases and disorders, pulmonary diseases and disorders, cardiovascular diseases and disorders, inflammation, inflammatory diseases and disorders, autoimmune diseases and disorders, cancer, oncological diseases and disorders, hematological diseases and disorders, tumorous diseases, neurological diseases and disorders and metabolic diseases and disorders

22.

TEZSBIRE

      
Application Number 212701900
Status Registered
Filing Date 2021-08-12
Registration Date 2023-08-23
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of respiratory diseases and disorders, pulmonary diseases and disorders, cardiovascular diseases and disorders, inflammation, inflammatory diseases and disorders, autoimmune diseases and disorders, cancer, oncological diseases and disorders, hematological diseases and disorders, tumorous diseases, neurological diseases and disorders and metabolic diseases and disorders

23.

TEZEPELUMAB Logo Design (colour)

      
Application Number 211438600
Status Registered
Filing Date 2021-06-16
Registration Date 2023-11-24
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of respiratory diseases and disorders, pulmonary diseases and disorders, cardiovascular diseases and disorders, inflammation, inflammatory diseases and disorders, autoimmune diseases and disorders, cancer, oncological diseases and disorders, hematological diseases and disorders, tumorous diseases, neurological diseases and disorders and metabolic diseases and disorders

24.

TEZEPELUMAB LOGO Design

      
Application Number 211438700
Status Registered
Filing Date 2021-06-16
Registration Date 2023-11-24
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of respiratory diseases and disorders, pulmonary diseases and disorders, cardiovascular diseases and disorders, inflammation, inflammatory diseases and disorders, autoimmune diseases and disorders, cancer, oncological diseases and disorders, hematological diseases and disorders, tumorous diseases, neurological diseases and disorders and metabolic diseases and disorders

25.

TRUHYA

      
Application Number 211210800
Status Registered
Filing Date 2021-06-04
Registration Date 2023-08-23
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of respiratory diseases and disorders, pulmonary diseases and disorders, cardiovascular diseases and disorders, inflammation, inflammatory diseases and disorders, autoimmune diseases and disorders, cancer, oncological diseases and disorders, hematological diseases and disorders, tumorous diseases, neurological diseases and disorders and metabolic diseases and disorders

26.

LUMYKRAS

      
Application Number 209733500
Status Registered
Filing Date 2021-04-06
Registration Date 2023-03-29
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in the prevention of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations for use in the treatment of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders

27.

TEZSPIRE

      
Application Number 208752300
Status Registered
Filing Date 2021-02-25
Registration Date 2023-08-23
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of respiratory diseases and disorders, pulmonary diseases and disorders, cardiovascular diseases and disorders, inflammation, inflammatory diseases and disorders, autoimmune diseases and disorders, cancer, oncological diseases and disorders, hematological diseases and disorders, tumorous diseases, neurological diseases and disorders and metabolic diseases and disorders

28.

LUMAKRAS

      
Application Number 207643300
Status Registered
Filing Date 2021-01-08
Registration Date 2023-08-23
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in the prevention of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations for use in the treatment of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders

29.

VALAKRAS

      
Application Number 206013300
Status Registered
Filing Date 2020-10-27
Registration Date 2023-12-01
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders

30.

HEART FAILURE LINK

      
Application Number 202845400
Status Pending
Filing Date 2020-05-14
Owner Amgen Inc. (USA)
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

(1) Providing a website featuring scientific information in the field of heart failure, risks therefor and treatments therefor; providing a website featuring technology that allows users to download copies of medical and scientific references in the field of heart failure, risks therefor and treatments therefor

31.

AUTOTOUCH CONNECT

      
Application Number 202839100
Status Registered
Filing Date 2020-05-14
Registration Date 2023-05-17
Owner Amgen Inc. (USA)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

(1) Injection device for pharmaceutical preparations, namely an injection device with wireless data communication technology for communicating with application software for controlling, tracking and monitoring injection of pharmaceutical preparations

32.

CODEBREAK

      
Application Number 202724400
Status Pending
Filing Date 2020-05-08
Owner Amgen Inc. (USA)
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

(1) Research and development of pharmaceutical preparations in the field of oncology; medical and scientific research information in clinical trials in the field of oncology; providing websites featuring medical and scientific research information about the diagnostic, prophylactic and therapeutic properties of pharmaceuticals in the field of oncology; providing websites featuring medical and scientific research information about pharmaceuticals preparations in the field of oncology; support services in the nature of a helpdesk, namely, providing medical and health information about the diagnostic, prophylactic and therapeutic properties of pharmaceuticals preparations in the field of oncology; providing online non-downloadable computer software used to access, manage, update and display electronic databases in the field of oncology

33.

MY HEARTPATH

      
Application Number 202252000
Status Pending
Filing Date 2020-04-15
Owner Amgen Inc. (USA)
NICE Classes  ?
  • 09 - Scientific and electric apparatus and instruments
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Downloadable application software for mobile devices to enable cardiovascular patients to record, manage and display healthcare information, health goals, and medical appointments (1) Providing healthcare information to patients on the patients' past cardiovascular events, steps to take in recovery, preparation for medical appointments, and setting and achieving health goals

34.

MY HEARTPATH Design

      
Application Number 202252100
Status Pending
Filing Date 2020-04-15
Owner Amgen Inc. (USA)
NICE Classes  ?
  • 09 - Scientific and electric apparatus and instruments
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Downloadable application software for mobile devices to enable cardiovascular patients to record, manage and display healthcare information, health goals, and medical appointments (1) Providing healthcare information to patients on the patients' past cardiovascular events, steps to take in recovery, preparation for medical appointments, and setting and achieving health goals

35.

AIMOVIG DIRECT

      
Application Number 202089800
Status Pending
Filing Date 2020-04-02
Owner Amgen Inc. (USA)
NICE Classes  ?
  • 35 - Advertising and business services
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Medical cost reimbursement assistance services, namely, providing assistance to patients relating to the reimbursement of medical expenses in the nature of business administration of patient reimbursement programs (2) Providing medical services and information to Health Care professionals and patients in the fields of prevention, management and treatment of headaches, migraine headaches, head pain, and neurological disorders and conditions, namely, brain injury, nausea, dizziness, and seizure disorders

36.

DROIT AU COEUR

      
Application Number 201631000
Status Pending
Filing Date 2020-03-09
Owner Amgen Inc. (USA)
NICE Classes  ?
  • 09 - Scientific and electric apparatus and instruments
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Downloadable application software for mobile devices to enable cardiovascular patients to record, manage and display healthcare information, health goals, and medical appointments (1) Providing healthcare information to patients on the patients' past cardiovascular events, steps to take in recovery, preparation for medical appointments, and setting and achieving health goals

37.

AMGEN

      
Application Number 199250900
Status Registered
Filing Date 2019-10-25
Registration Date 2023-05-10
Owner Amgen Inc. (USA)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

(1) Drug delivery devices, namely, electromechanical onbody injectors for delivery of a drug; drug delivery systems, namely injection needles, injection syringes; injection devices for pharmaceutical preparations, namely, an injection device capable of wireless communication with software on a separate device, autoinjectors for pharmaceutical preparations; injectors for medical purposes; syringes for pharmaceutical preparations

38.

ADVANCING ONCOLOGY AT THE SPEED OF LIFE

      
Application Number 198033600
Status Pending
Filing Date 2019-08-13
Owner Amgen Inc. (USA)
NICE Classes  ? 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Pharmaceutical preparations; pharmaceutical preparations in the field of oncology; Providing health and medical information; providing information to patients in the field of administering medications; providing health information for patient support services; providing health and medical information in the fields of oncology and oncological disorders or conditions; providing a website featuring medical support information for patients in the fields of oncology and oncological disorders or conditions

39.

RIABNI

      
Application Number 196117300
Status Registered
Filing Date 2019-05-06
Registration Date 2021-07-21
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for treatment of oncologic, and auto-immune diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders, namely Ankylosing spondylitis, scleroderma, asthma, celiac disease, gout, rheumatoid arthritis, prostatitis, colitis, diverticulitis, glomerulonephritis, hidradenitis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, cystitis, myositis, lupus, mast cell activation syndrome, mastocytosis, otitis, sarcoidosis, transplant rejection, and vasculitis; pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the blood, skin, namely dermatitis, eczema, psoriasis, bone marrow, central nervous system, namely brain, movement, ocular motility and spinal cord diseases, immune system and joints; pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), pemphigus vulgaris (PV), multiple sclerosis (MS), and stem cell transplantation

40.

COVASCERT

      
Application Number 196094800
Status Registered
Filing Date 2019-05-03
Registration Date 2021-07-21
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in the treatment of cancer, autoimmune diseases, inflammation, inflammatory diseases and disorders, namely, Ankylosing spondylitis, scleroderma, asthma, celiac disease, gout, rheumatoid arthritis, prostatitis, colitis, diverticulitis, glomerulonephritis, hidradenitis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, cystitis, myositis, lupus, mast cell activation syndrome, mastocytosis, otitis, sarcoidosis, transplant rejection, and vasculitis, neurologic diseases and disorders, namely, Amyotrophic lateral sclerosis (ALS), Alzheimer's disease, aneurysm, back pain, Bell's palsy, brain tumor, brain injury, Cerebral palsy, chronic fatigue syndrome, concussion, dementia, disk disease of neck and lower back, dizziness, epilepsy, Guillain-Barré syndrome, headaches and migraines, multiple sclerosis, muscular dystrophy, neuralgia, neuropathy, neuromuscular and related diseases, Parkinson's disease, severe depression, seizure disorders, obsessive-compulsive disorder, anxiety disorders, cognitive disorders, schizophrenia, scoliosis, spinal deformity and disorders, spine tumor, spinal cord injury, stroke, and vertigo, metabolic diseases and disorders, namely, diabetes, obesity, hypoglycaemia, cystic fibrosis, osteoarthritis, muscular dystrophy, and anemia, and cardiovascular diseases and disorders; pharmaceutical preparations for suppressing tumours

41.

AIMOVIG DIRECT

      
Application Number 196094700
Status Pending
Filing Date 2019-05-03
Owner Amgen Inc. (USA)
NICE Classes  ?
  • 35 - Advertising and business services
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Medical cost reimbursement assistance services, namely, providing assistance to patients relating to the reimbursement of medical expenses in the nature of business administration of patient reimbursement programs (2) Providing medical services and information to Health Care professionals and patients in the fields of prevention, management and treatment of headaches, migraine headaches, head pain, and neurological disorders and conditions, namely, brain injury, nausea, dizziness, and seizure disorders

42.

AMGEN ENTRUST

      
Application Number 195330400
Status Registered
Filing Date 2019-03-25
Registration Date 2023-06-06
Owner Amgen Inc. (USA)
NICE Classes  ?
  • 35 - Advertising and business services
  • 36 - Financial, insurance and real estate services
  • 39 - Transport, packaging, storage and travel services
  • 41 - Education, entertainment, sporting and cultural services
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
  • 45 - Legal and security services; personal services for individuals.

Goods & Services

(1) Administration of patient reimbursement programs and co-pay support programs; providing healthcare administration, namely, providing insurance verification and prior authorization services, namely, verifying insurance eligibility status and providing related insurance information in the field of healthcare, for others;referral services in the field of co-pay assistance programs; insurance services in the form of insurance verification services and prior authorization services, namely, verifying insurance eligibility status and related information; providing free medical supplies to others, namely, sharps containers and travel coolers for medical purposes (2) Providing personal support services for families of patients in the form of patient support services relating to treatment of medical disorders, namely, travel arrangements (3) Training in the field of patient support services relating to treatment of medical disorders, namely, injection training and drug fill/refill support, providing emails/SMS regarding injection and refill schedules, compliance calls and medical disorder education; providing electronic or print newsletters relating to the treatment of medical disorders via email (4) Patient support services relating to treatment of medical disorders, namely, providing information to patients and families of patients in the field of administering medication, and patient medical information where patients can inquire about medical issues and procedures from medical personnel; providing information to patients in the field of administering medications (5) Providing personal support services for families of patients in the form of patient support services relating to treatment of medical disorders, namely, companionship, help with medical forms, personal emotional counseling, and emotional support

43.

IMLYGIC

      
Application Number 194245100
Status Registered
Filing Date 2019-01-24
Registration Date 2020-11-05
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in the treatment of oncological diseases and disorders

44.

AUTOTOUCH

      
Application Number 194249900
Status Registered
Filing Date 2019-01-24
Registration Date 2022-11-18
Owner Amgen Inc. (USA)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

(1) Injection device for pharmaceutical preparations, namely, autoinjectors for pharmaceutical preparations.

45.

IMLYGIC Logo

      
Application Number 194245200
Status Registered
Filing Date 2019-01-24
Registration Date 2020-11-03
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in the treatment of oncological diseases and disorders.

46.

OMLIVULT

      
Application Number 193626800
Status Registered
Filing Date 2018-12-14
Registration Date 2020-11-30
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in the treatment of cancer, autoimmune diseases, inflammation, inflammatory diseases and disorders, namely, Ankylosing spondylitis, scleroderma, asthma, celiac disease, gout, rheumatoid arthritis, prostatitis, colitis, diverticulitis, glomerulonephritis, hidradenitis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, cystitis, myositis, lupus, mast cell activation syndrome, mastocytosis, otitis, sarcoidosis, transplant rejection, and vasculitis, neurologic diseases and disorders, namely, Amyotrophic lateral sclerosis (ALS), Alzheimer's disease, aneurysm, back pain, Bell's palsy, brain tumor, brain injury, Cerebral palsy, chronic fatigue syndrome, concussion, dementia, disk disease of neck and lower back, dizziness, epilepsy, Guillain-Barré syndrome, headaches and migraines, multiple sclerosis, muscular dystrophy, neuralgia, neuropathy, neuromuscular and related diseases, Parkinson's disease, severe depression, seizure disorders, obsessive-compulsive disorder, anxiety disorders, cognitive disorders, schizophrenia, scoliosis, spinal deformity and disorders, spine tumor, spinal cord injury, stroke, and vertigo, metabolic diseases and disorders, namely, diabetes, obesity, hypoglycaemia, cystic fibrosis, osteoarthritis, muscular dystrophy, and anemia, and cardiovascular diseases and disorders; pharmaceutical preparations for suppressing tumours

47.

GANVADO

      
Application Number 193627000
Status Registered
Filing Date 2018-12-14
Registration Date 2020-12-21
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in the treatment of cancer, autoimmune diseases, inflammation, inflammatory diseases and disorders, namely, asthma, celiac disease, atopic dermatitis, chronic obstructive pulmonary disease, osteoarthritis, prostatitis, colitis, diverticulitis, glomerulonephritis, hidradenitis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, cystitis, mast cell activation syndrome, mastocytosis, otitis, sarcoidosis, transplant rejection, and vasculitis, neurologic diseases and disorders, namely, brain injury, spinal cord injury, seizure disorders, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia, metabolic diseases and disorders, namely, diabetes, hypoglycemia, hypercalcemia, hyperparathyroidism, hypercholesterolemia, hypocalcemia, obesity, gout, muscular dystrophy, and anemia, and cardiovascular diseases and disorders; pharmaceutical preparations for suppressing tumours

48.

TLOGEX

      
Application Number 193626900
Status Registered
Filing Date 2018-12-14
Registration Date 2020-12-21
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in the treatment of cancer, autoimmune diseases, inflammation, inflammatory diseases and disorders, namely, asthma, celiac disease, atopic dermatitis, chronic obstructive pulmonary disease, osteoarthritis, prostatitis, colitis, diverticulitis, glomerulonephritis, hidradenitis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, cystitis, mast cell activation syndrome, mastocytosis, otitis, sarcoidosis, transplant rejection, and vasculitis, neurologic diseases and disorders, namely, brain injury, spinal cord injury, seizure disorders, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia, metabolic diseases and disorders, namely, diabetes, hypoglycemia, hypercalcemia, hyperparathyroidism, hypercholesterolemia, hypocalcemia, obesity, gout, muscular dystrophy, and anemia, and cardiovascular diseases and disorders; pharmaceutical preparations for suppressing tumours

49.

AVSOLA

      
Application Number 192657900
Status Registered
Filing Date 2018-10-23
Registration Date 2020-11-13
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for treatment of autoimmune diseases and disorders.

50.

AYATI

      
Application Number 192657700
Status Registered
Filing Date 2018-10-23
Registration Date 2021-03-17
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for treatment of autoimmune diseases and disorders.

51.

REPÈREREPATHA

      
Application Number 188505200
Status Registered
Filing Date 2018-02-26
Registration Date 2020-07-27
Owner Amgen Inc. (USA)
NICE Classes  ?
  • 35 - Advertising and business services
  • 36 - Financial, insurance and real estate services
  • 39 - Transport, packaging, storage and travel services
  • 41 - Education, entertainment, sporting and cultural services
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
  • 45 - Legal and security services; personal services for individuals.

Goods & Services

(1) Administration of patient reimbursement programs and co-pay support programs; referral services in the field of co-pay assistance programs; free distribution of medical supplies, namely, sharps containers and travel coolers for medical purposes in connection therewith (2) Providing healthcare administration, namely, providing insurance verification and prior authorization services, namely, verifying insurance eligibility status and providing related insurance information in the field of healthcare, for others; insurance services in the form of insurance verification services and prior authorization services, namely, verifying insurance eligibility status and related information (3) Training in the field of patient support services relating to treatment of medical disorders, namely, injection training and drug refill support, providing emails regarding injection and refill schedules, compliance calls and medical disorder education; providing electronic newsletters relating to the treatment of medical disorders via email; providing information to patients in the field of administering medications (4) Patient support services relating to treatment of medical disorders, namely, providing information to patients and families of patients in the field of administering medication, and patient medical information where patients can inquire about medical issues and procedures from medical personnel (5) Providing personal support services for families of patients in the form of patient support services relating to treatment of medical disorders, namely, companionship, help with medical forms, counseling and emotional support

52.

Miscellaneous Logo

      
Application Number 185904700
Status Registered
Filing Date 2017-09-22
Registration Date 2020-05-21
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in the treatment of tumorous diseases; B-cell disorders, namely leukemia, lymphoma, multiple myeloma, humoral immune deficiency, and plasma cell proliferative disease; autoimmune diseases; inflammation, namely asthma, celiac disease, prostatitis, colitis, diverticulitis, glomerulonephritis, hidradenitis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, cystitis, mast cell activation syndrome, mastocytosis, otitis, sarcoidosis, transplant rejection, and vasculitis; infectious diseases, namely urinary tract infection, skin infection, respiratory tract infection, odontogenic infection, vaginal infection, and amniotic infection; and minimal residual disease, namely cancer cells from bone marrow.

53.

EVENITY RIBBON ICON Design

      
Application Number 185092100
Status Registered
Filing Date 2017-08-03
Registration Date 2019-11-11
Owner Amgen Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Pharmaceutical preparations used for the treatment of osteoporosis, bone disorders, bone diseases, skeletal disorders and skeletal diseases; pharmaceutical preparations used for increasing bone density, bone formation and bone growth. (1) Providing online publications in the nature of brochures and newsletters in the fields of pharmaceuticals, medicines, bone disorders, and general health and well-being; arranging and conducting classes, seminars and workshops in the fields of pharmaceuticals, medicines, bone disorders and general health and well-being; educational services, namely, educational courses about pharmaceuticals, medicines, bone disorders and general health and well-being accessible by means of audio, video, web-based applications, mobile phone applications, and computer networks; educational services, namely, conducting programs in the fields of pharmaceuticals, medicines, bone disorders and health. (2) Research and development of pharmaceutical preparations and medicines; pharmaceutical research and development; research and development in the field of biotechnology; providing medical and scientific research information in the fields of pharmaceutical preparations, medicines and clinical trials; providing websites featuring medical and scientific research information about the diagnostic, prophylactic and therapeutic properties of pharmaceuticals preparations and medicines; providing websites featuring medical and scientific research information about pharmaceuticals preparations and medicines; support services in the nature of a helpdesk, namely, providing medical and health information about the diagnostic, prophylactic and therapeutic properties of pharmaceuticals preparations and medicines; providing online non-downloadable computer software used to access, manage, update and display electronic databases in the fields of pharmaceutical preparations and medicines.

54.

AIMOVIG

      
Application Number 185043300
Status Registered
Filing Date 2017-08-01
Registration Date 2019-07-17
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations used for the prevention, management and treatment of headaches, migraine headaches, and head pain, and for the prevention, management and treatment of neurological disorders and conditions, namely, brain injury, nausea, dizziness, and seizure disorders.

55.

ERENUMAB Design

      
Application Number 185042700
Status Registered
Filing Date 2017-08-01
Registration Date 2019-08-20
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations used for the prevention, management and treatment of headaches, migraine headaches, head pain, and neurological disorders and conditions namely, brain injury, nausea, dizziness, and seizure disorders.

56.

CESTRATA

      
Application Number 183076700
Status Registered
Filing Date 2017-04-03
Registration Date 2019-09-26
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in the treatment of cancer, malignant tumours and for suppressing tumors; pharmaceutical preparations for use in the treatment of autoimmune diseases, inflammation, inflammatory diseases and disorders, neurologic diseases and disorders, namely, brain injury, spinal cord injury, seizure disorders, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis and Huntington's disease; pharmaceutical preparations for use in the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; and pharmaceutical preparations for use in the treatment of cardiovascular diseases and disorders.

57.

AVSOLA

      
Application Number 182969100
Status Registered
Filing Date 2017-03-28
Registration Date 2019-12-16
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations used for the treatment of cancer.

58.

KYOMARC

      
Application Number 182969200
Status Registered
Filing Date 2017-03-28
Registration Date 2019-12-16
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations used for the treatment of cancer

59.

MVASI

      
Application Number 182969000
Status Registered
Filing Date 2017-03-28
Registration Date 2019-12-13
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations used for the treatment of cancer.

60.

REXADEV

      
Application Number 182081100
Status Registered
Filing Date 2017-02-01
Registration Date 2019-11-04
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations, biosimilars and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations, biosimilars and substances for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations, biosimilars and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, Pyoderma Gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma.

61.

AIMOVIG

      
Application Number 181252200
Status Registered
Filing Date 2016-12-05
Registration Date 2019-07-17
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations used for the prevention, management and treatment of headaches, migraine headaches, head pain, and neurological disorders, namely, brain injury, nausea, dizziness, and seizure disorders.

62.

EVENITY

      
Application Number 181009100
Status Registered
Filing Date 2016-11-18
Registration Date 2019-08-07
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations used for the treatment of osteoporosis, bone disorders, bone diseases, skeletal disorders and skeletal diseases; pharmaceutical preparations used for increasing bone density, bone formation and bone growth

63.

MISC DESIGN (EVENITY)

      
Application Number 181009200
Status Registered
Filing Date 2016-11-18
Registration Date 2019-08-07
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations used for the treatment of osteoporosis, bone disorders, bone diseases, skeletal disorders and skeletal diseases; pharmaceutical preparations used for increasing bone density, bone formation and bone growth

64.

TRUECLICK

      
Application Number 180670600
Status Registered
Filing Date 2016-10-27
Registration Date 2019-06-25
Owner Amgen Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

(1) Injectors for medical purposes, namely, autoinjectors for pharmaceutical preparations, excluding injectors for growth hormone products

65.

PARSABIV

      
Application Number 180546100
Status Registered
Filing Date 2016-10-19
Registration Date 2019-07-12
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations used for the treatment of parathyroid disorders; pharmaceutical preparations used for the treatment of renal and kidney disorders.

66.

MISC THREE RING DESIGN

      
Application Number 180545700
Status Registered
Filing Date 2016-10-19
Registration Date 2019-10-11
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations used for the treatment of parathyroid disorders; pharmaceutical preparations used for the treatment of renal and kidney disorders

67.

PUSHTRONEX

      
Application Number 179648200
Status Registered
Filing Date 2016-08-18
Registration Date 2019-08-13
Owner Amgen Inc. (USA)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

(1) Drug delivery devices, namely, electromechanical onbody injectors for delivery of a drug.

68.

AMJEVITA

      
Application Number 179376700
Status Registered
Filing Date 2016-07-29
Registration Date 2019-07-24
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Biosimilars, pharmaceutical preparations and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; biosimilars, pharmaceutical preparations and substances for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; biosimilars, pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, crohn's disease, ulcerative colitis, intestinal behçet's disease, chronic pouchitis, small bowel lesions, hermansky-pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, pyoderma gangrenosum, giant cell arteritis, netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma.

69.

AMGEN

      
Application Number 177697200
Status Registered
Filing Date 2016-04-12
Registration Date 2018-10-19
Owner Amgen Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 35 - Advertising and business services
  • 36 - Financial, insurance and real estate services
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Pharmaceutical preparations, namely, erythropoietin for use in treating chronic anemia, granulocyte colony stimulation factor and granulocyte-macrophage colony stimulating factor for use in restoring the level of white blood cells, epidermal growth factor and platelet-derived growth factor for use in treating surgical or soft tissue damage (2) Pharmaceutical preparations, namely, human recombinant erythropoietin and erythropoiesis stimulating protein preparations, pharmaceutical preparations for use in stimulating production of red blood cells, white blood cells and platelets, pharmaceutical preparations for modulating calcium, phosphorus, and parathyroid hormone levels in the blood and for treatment of hyperparathyroidism, hypercalcemia and bone metabolism related disorders and diseases, pharmaceutical preparations for the treatment of viral infections, neoplastic diseases and disorders, pharmaceutical preparations for the treatment of anemia, ankylosing spondylitis, arthritis, asthma, cancer, cardiovascular conditions, collection by leukopheresis, effects of myelosuppressive chemotherapy, effects of myelosuppressive doses of radiation, glandular disorders, hormone disorders, hypercalcemia, hyperparathyroidism, hyperphosphatemia, inflammatory bowel disease, kidney disorders and disease, lupus, migraine, neutropenia, osteoporosis, parathyroid disorders, psoriasis, reduction of red blood cell transfusions, renal disorders, Sjoegren's syndrome, thrombocytopenia and Wegener's granulomatosis, the aforementioned pharmaceutical preparations sold in pre-filled syringes for medical purposes and for injections (3) Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of oncological diseases and disorders and their complications, pharmaceutical preparations for stimulating the growth of platelets and platelet precursor cells, erythropoiesis stimulating protein, pharmaceutical preparations for stimulating white blood cell production, pharmaceutical preparations for modulating the level of calcium in the bloodstream and for the treatment of hyperparathyroidism and hypercalcemia, pharmaceutical preparations for the treatment of bone disease, the aforementioned pharmaceutical preparations sold in pre-filled syringes for medical purposes and for injections (1) Referral services in the field of treatment for cancer, chemotherapy and pharmaceutical products (2) Administration of patient reimbursement programs (3) Educational services, namely development and dissemination of educational materials of others in the fields of pharmaceutical products and treatment of medical disorders; conducting seminars regarding the use of prescription pharmaceutical products for medical disorders; providing a motivational and educational speaker featuring information regarding medical disorders (4) Genetic engineering research and development services for others (5) Medical research, namely, clinical trial services (6) Patient support services relating to the treatment of medical disorders, namely, providing online information regarding pharmaceutical preparations for treatment of various diseases; providing health and medical information about medical disorders; information services, namely, providing medical information to cancer patients; medical consultancy in the field of pharmaceutical products and treatment of medical disorders via a global computer network

70.

RIBBON LOGO DESIGN

      
Application Number 177023300
Status Registered
Filing Date 2016-03-01
Registration Date 2021-09-28
Owner Amgen Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Pharmaceutical preparations and substances used for the treatment of bone, joint, vertebral column, intestine, colorectal cancer, colonic polyps, ulcerative colitis, diverticulitis, irritable bowel syndrome, colon cancer, skin and skin structure infections namely, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema, dermatitis, bullous skin disorder, skin pigmentation diseases, skin cancer, psoriasis, lung asthma, asthma, refractory asthma, lung cancer, retinal vascular disorders, uveitis, choroidal neovascularization, pharmaceutical preparations for use in ophthalmology, pharmaceutical preparations for use in ocular disorders, breast cancer, ovarian cancer, cervical cancer, gastric cancer, interstitial cystitis, kidney failure, graft-versus-host disease following kidney transplant, pharmaceutical preparations for the treatment of headaches and migraine headaches, brain, neck, and blood diseases and disorders; Pharmaceutical preparations and substances for the treatment of autoimmune, autoimmune diseases, immunologic deficiency syndromes, rheumatoid arthritis, lymphoma, leukemia, inflammatory connective tissue, inflammatory bowel, gastrointestinal, sexually transmitted diseases, urological diseases, infertility, inflammatory pelvic diseases, connective tissue diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement, osteoarthritis, bone cancer, bone density deficiency, psoriatic arthritis, arthritis, dermatitis, skin pigmentation diseases, skin cancer, respiratory diseases, respiratory infections, pharmaceutical preparations for the treatment of the respiratory system, respiratory, oncological, hepatological, lymphomas, leukemias, ophthalmic, transplant rejection, cardiovascular, growth and thyroid diseases, hormone deficiency, Parkinson's disease, Alzheimer's Disease, Huntington's Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia, sleep, muscular dystrophy and atrophy, brain cancer, sleep, muscular, and psychiatric diseases namely, mood, anxiety, cognitive, and schizophrenia, diseases and disorders; Pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, polymyalgia rheumatic, spondyloarthropathies, acute disc prolapse, inflammatory bowel disease, crohn's disease, ulcerative colitis, intestinal behçet's disease, chronic pouchitis, small bowel lesions, hermansky-pudlak syndrome, autoimmune pancreatitis, multiple myeloma, multiple sclerosis, systemic lupus erythematosus, lupus nephritis, chronic inflammatory demyelinating polyneuropathy, autoimmune anemia, autoimmune hemolytic anemia, pure red cell aplasia, idiopathic thrombocytopenic purpura, evans syndrome, type 1 diabetes mellitus, sjogren's syndrome, encephalitis, igg4-related disease, devic's disease, myositis, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, palmoplantar psoriasis, hidradenitis suppurativa, bullous skin disorder, pemphigus, pemphigoid, kawasaki disease, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, agerelated macular degeneration, refractory diabetic macular edema, uveitis, childhood uveitis, uveitic macular edema, choroidal neovascularization, graves' ophthalmopathy, pyoderma gangrenosum, giant cell arteritis, netherton syndrome, anaplastic thyroid cancer, breast cancer, ovarian cancer, cervical cancer, gastric cancer, colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, head and neck cancer, non-hodgkin's lymphoma, chronic lymphocytic leukemia, lymphocyte predominant subtype of hodgkin's lymphoma, vasculitis, granulomatosis with polyangiitis, microscopic polyangiitis, graft-versus-host disease, graft-versus-host disease following allogenic hematopoietic stem cell transplantation, graft-versus-host disease following keratoprosthesis, kidney transplant, asthma, chronic fatigue syndrome, major depression, and bipolar depression. (1) Providing online publications in the nature of brochures and newsletters in the fields of pharmaceuticals, biosimilars, medicines and health; Arranging and conducting classes, seminars and workshops in the fields of pharmaceuticals, biosimilars and medicines; Educational services, namely, programs about pharmaceuticals, biosimilars and medicines accessible by means of audio, video, web-based applications, mobile phone applications, and computer networks; Educational services, namely, conducting programs in the fields of pharmaceuticals, biosimilars and medicines. (2) Research and development of pharmaceutical preparations and biosimilars; Research and development in the pharmaceutical and biotechnology fields; Medical and scientific research information in the fields of pharmaceutical preparations, biosimilars and clinical trials; Providing online non-downloadable computer software used to access, manage, update and display electronic databases in the fields of pharmaceutical preparations and biosimilars; Computer software used to access, manage, update and display online electronic databases in the fields of pharmaceutical preparations and biosimilars. (3) Providing information about pharmaceutical preparations and biosimilars via a website; Pharmaceutical and biosimilar support services, namely, help desk services.

71.

AMGEVITA

      
Application Number 177023400
Status Registered
Filing Date 2016-03-01
Registration Date 2019-06-18
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, crohn's disease, ulcerative colitis, intestinal behçet's disease, chronic pouchitis, small bowel lesions, hermansky-pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, pyoderma gangrenosum, giant cell arteritis, netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma.

72.

EVENITY

      
Application Number 175994800
Status Registered
Filing Date 2015-12-16
Registration Date 2019-06-18
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations used for the treatment of osteoporosis, bone disorders, bone diseases, skeletal disorders and skeletal diseases; pharmaceutical preparations used for increasing bone density, bone formation and bone growth

73.

MIVELI

      
Application Number 175996200
Status Registered
Filing Date 2015-12-16
Registration Date 2019-06-18
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations used for the treatment of osteoporosis, bone disorders, bone diseases, skeletal disorders and skeletal diseases; pharmaceutical preparations used for increasing bone density, bone formation and bone growth

74.

OTTETTO

      
Application Number 175996400
Status Registered
Filing Date 2015-12-16
Registration Date 2019-06-18
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations used for the treatment of osteoporosis, bone disorders, bone diseases, skeletal disorders and skeletal diseases; pharmaceutical preparations used for increasing bone density, bone formation and bone growth

75.

KINDLIA

      
Application Number 175943800
Status Registered
Filing Date 2015-12-14
Registration Date 2019-12-10
Owner AMGEN INC. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations used for the treatment of parathyroid, glandular and hormone disorders; pharmaceutical preparations used for the treatment of renal and kidney disorders.

76.

AMGEN BIOSIMILARS

      
Application Number 174561100
Status Registered
Filing Date 2015-09-11
Registration Date 2019-07-16
Owner Amgen Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 35 - Advertising and business services
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) House mark for a full line of pharmaceuticals, namely, pharmaceutical preparations and substances for the treatment of autoimmune, immune system, inflammatory, namely inflammatory connective tissue, inflammatory bowel, gastrointestinal, genitourinary, musculoskeletal, namely connective tissue diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis, dermatological, namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases, pulmonary, respiratory, oncological, hepatological, namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis, lymphomas, leukemias, ophthalmic, transplant rejection, cardiovascular, endocrine namely growth and thyroid, neurological, namely Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia, sleep, muscular, namely muscular dystrophy and atrophy, and psychiatric, namely, mood, anxiety, cognitive, and schizophrenia, diseases and disorders; pharmaceutical preparations and substances used for the treatment of bone, joint, vertebral column, gastro-intestinal, colon, namely colorectal cancer, colonic polyps, ulcerative colitis, diverticulitis, irritable bowel syndrome, skin, namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases, psoriasis, psoriatic arthritis and lung asthma, cancer, osteoporosis, kidney failure, arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, crohn's disease, ulcerative colitis, intestinal behçet's disease, chronic pouchitis, small bowel lesions, hermansky-pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, pyoderma gangrenosum, giant cell arteritis, netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma, and blood diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune, immune system, inflammatory, namely inflammatory connective tissue, inflammatory bowel, gastrointestinal, genitourinary, musculoskeletal, namely connective tissue diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis, dermatological, namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases, pulmonary, respiratory, oncological, hepatological, namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis, lymphomas, leukemias, ophthalmic, transplant rejection, cardiovascular, endocrine namely growth and thyroid, neurological, namely Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia, sleep, muscular, namely muscular dystrophy and atrophy, and psychiatric, namely, mood, anxiety, cognitive, and schizophrenia, diseases and disorders; pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, polymyalgia rheumatic, spondyloarthropathies, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, autoimmune pancreatitis, multiple myeloma, multiple sclerosis, systemic lupus erythematosus, lupus nephritis, chronic inflammatory demyelinating polyneuropathy, autoimmune anemia, autoimmune hemolytic anemia, pure red cell aplasia, idiopathic thrombocytopenic purpura, Evans syndrome, type 1 diabetes mellitus, Sjogren's syndrome, encephalitis, IgG4-related disease, Devic's disease, myositis, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, palmoplantar psoriasis, hidradenitis suppurativa, bullous skin disorder, pemphigus, pemphigoid, kawasaki disease, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, age-related macular degeneration, refractory diabetic macular edema, uveitis, childhood uveitis, uveitic macular edema, choroidal neovascularization, Graves' ophthalmopathy, pyoderma gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancer, breast cancer, ovarian cancer, cervical cancer, gastric cancer, colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, head and neck cancer, Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, lymphocyte predominant subtype of Hodgkin's Lymphoma, vasculitis, granulomatosis with polyangiitis, microscopic polyangiitis, graft-versus-host disease, graft-versus-host disease following allogenic hematopoietic stem cell transplantation, graft-versus-host disease following keratoprosthesis, kidney transplant, asthma, chronic fatigue syndrome, major depression, and bipolar depression (1) Providing non-downloadable online publications in the nature of brochures and newsletters in the fields of pharmaceuticals, biosimilars, medicines and health; arranging and conducting classes, seminars and workshops in the fields of pharmaceuticals, biosimilars, medicines and health; educational services, namely, programs about pharmaceuticals, biosimilars, medicines and health accessible by means of audio, video, web-based applications, mobile phone applications, and computer networks; educational services, namely, conducting programs in the fields of pharmaceuticals, biosimilars, medicines and health (2) Research and development of pharmaceutical preparations and biosimilars; research and development in the pharmaceutical and biotechnology fields; medical and scientific research information in the fields of pharmaceutical preparations, biosimilars and clinical trials; providing websites featuring information about pharmaceutical preparations and biosimilars; pharmaceutical and biosimilar support services, namely, help desk services; providing non-downloadable online computer software used to access, manage, update and display electronic databases in the fields of pharmaceutical preparations and biosimilars

77.

PARSABIV

      
Application Number 173808300
Status Registered
Filing Date 2015-07-20
Registration Date 2019-06-18
Owner AMGEN INC. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations used for the treatment of parathyroid, glandular and hormone disorders; pharmaceutical preparations used for the treatment of renal and kidney disorders

78.

Circle Design

      
Application Number 173436500
Status Registered
Filing Date 2015-06-25
Registration Date 2019-06-17
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of cholesterol related diseases and disorders

79.

DEPTARGIS

      
Application Number 170221000
Status Registered
Filing Date 2014-11-12
Registration Date 2019-06-25
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of oncological diseases and disorders

80.

DOSEALLY

      
Application Number 167553000
Status Registered
Filing Date 2014-05-05
Registration Date 2019-06-25
Owner Amgen Inc., a Delaware corporation (USA)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

(1) Drug delivery device, namely, electromechanical onbody injector for delivery of a drug.

81.

REPATHA

      
Application Number 166242600
Status Registered
Filing Date 2014-02-04
Registration Date 2017-01-25
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of cholesterol related diseases and disorders.

82.

KANJINTI

      
Application Number 164245700
Status Registered
Filing Date 2013-09-06
Registration Date 2019-07-08
Owner Amgen Inc. (a Delaware corporation) (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in the treatment of oncological diseases and disorders.

83.

NPlate Design

      
Application Number 154697000
Status Registered
Filing Date 2011-10-07
Registration Date 2013-04-09
Owner Amgen Inc., a Delaware corporation (USA)
NICE Classes  ? 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Providing medical information and patient support services, namely, pharmaceutical advice and consultation in the nature of providing online information regarding immune thrombocytopenic purpura; providing health and medical information about immune thrombocytopenic purpura; information services, namely, providing medical information to ITP patients; providing medical consultancy and advisory services via a global computer network in the field of immune thrombocytopenic purpura.

84.

VICTORY

      
Application Number 147705200
Status Registered
Filing Date 2010-04-15
Registration Date 2012-03-19
Owner Amgen Inc. (a Delaware corporation) (USA)
NICE Classes  ? 35 - Advertising and business services

Goods & Services

(1) Administration of patient reimbursement programs; administration of services to facilitate patient access to prescription drug reimbursement; administration of services to facilitate access to or delivery of prescription drugs; administration of services to facilitate patient adherence to therapy regimens.

85.

PROVITALE

      
Application Number 145958100
Status Registered
Filing Date 2009-11-18
Registration Date 2012-08-23
Owner Amgen Inc. (USA)
NICE Classes  ?
  • 35 - Advertising and business services
  • 36 - Financial, insurance and real estate services
  • 41 - Education, entertainment, sporting and cultural services

Goods & Services

(1) Administration of prescription drug co-payment programs; administration of patient reimbursement programs; administration of services to facilitate access to or delivery of prescription drugs; administration of services to facilitate patient adherence to therapy regimens.

86.

PROVITAL

      
Application Number 145581200
Status Registered
Filing Date 2009-10-19
Registration Date 2012-08-23
Owner Amgen Inc. (USA)
NICE Classes  ?
  • 35 - Advertising and business services
  • 36 - Financial, insurance and real estate services
  • 41 - Education, entertainment, sporting and cultural services

Goods & Services

(1) Administration of prescription drug co-payment programs; administration of patient reimbursement programs; administration of services to facilitate access to or delivery of prescription drugs; administration of services to facilitate patient adherence to therapy regimens.

87.

AMGEN RENAL ADVANCES

      
Application Number 143469900
Status Registered
Filing Date 2009-04-15
Registration Date 2010-05-20
Owner Amgen Inc. (USA)
NICE Classes  ?
  • 35 - Advertising and business services
  • 41 - Education, entertainment, sporting and cultural services

Goods & Services

(1) Educational support programs, namely referral services in the field of pharmaceutical products; development and dissemination of educational materials of others in the field of pharmaceutical products.

88.

BONE ACADEMY

      
Application Number 142772800
Status Registered
Filing Date 2009-02-12
Registration Date 2012-09-13
Owner Amgen Inc. (USA)
NICE Classes  ? 41 - Education, entertainment, sporting and cultural services

Goods & Services

(1) Informational and educational services in the field of osteoporosis.

89.

Miscellaneous Design

      
Application Number 141810100
Status Registered
Filing Date 2008-11-12
Registration Date 2011-10-27
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of bone disease.

90.

PSORIASIS CONNECTIONS

      
Application Number 139564800
Status Registered
Filing Date 2008-05-14
Registration Date 2009-11-10
Owner Amgen Inc. (USA)
NICE Classes  ? 41 - Education, entertainment, sporting and cultural services

Goods & Services

(1) Educational services, namely, development and dissemination of educational materials of others in the field of psoriasis and the treatment thereof.

91.

PROLIA

      
Application Number 136916000
Status Registered
Filing Date 2007-10-25
Registration Date 2010-10-01
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of bone disease.

92.

XGEVA

      
Application Number 131143000
Status Registered
Filing Date 2006-08-02
Registration Date 2011-09-28
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders and complications associated therewith.

93.

NPLATE

      
Application Number 130162800
Status Registered
Filing Date 2006-05-16
Registration Date 2009-11-27
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of human diseases, namely, for use in stimulating blood cell production.

94.

SURECLICK

      
Application Number 123859100
Status Registered
Filing Date 2004-11-25
Registration Date 2007-12-12
Owner Amgen Inc. (USA)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

(1) Injectors for medical purposes, excluding injectors for growth hormone products.

95.

MISCELLANEOUS Design

      
Application Number 121792200
Status Registered
Filing Date 2004-05-25
Registration Date 2005-04-19
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations namely, pharmaceuticals used for stimulating white blood cell production.

96.

ARANESP AIDE PROGRAM

      
Application Number 120937500
Status Registered
Filing Date 2004-03-11
Registration Date 2006-11-24
Owner Amgen Inc. (USA)
NICE Classes  ?
  • 35 - Advertising and business services
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Provision of assistance in obtaining access to useful articles such as schedule organizers, blankets, and sharps containers; operation of a program providing assistance to patients receiving anemia therapy: assistance with obtaining reimbursement for treatment costs through private insurance and provincial drug benefit plans; provision of patient support services namely reminder services regarding timing of anemia drug therapy (2) Operation of a program providing assistance to patients receiving anemia therapy: provision of information regarding anemia treatment

97.

NEULASTA

      
Application Number 112844100
Status Registered
Filing Date 2002-01-18
Registration Date 2004-12-31
Owner AMGEN INC. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations namely, pharmaceuticals used for stimulating white blood cell production.

98.

SENSIPAR

      
Application Number 108942000
Status Registered
Filing Date 2001-01-17
Registration Date 2005-02-22
Owner Amgen Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical products, namely pharmaceuticals for modulating the level of calcium in the bloodstream and for the treatment of hyperparathyroidism and hypercalcemia.

99.

ARANESP

      
Application Number 103656100
Status Registered
Filing Date 1999-11-16
Registration Date 2004-09-07
Owner AMGEN INC., (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Prescription pharmaceuticals for use in stimulating red blood cell production; prescription pharmaceuticals, namely, erythropoiesis stimulating protein.

100.

SINGLEJECT

      
Application Number 101249700
Status Registered
Filing Date 1999-04-19
Registration Date 2001-09-17
Owner Amgen Inc., (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparation sold in prefilled syringes for use in connection with one or more of the following - the treatment of viral, neoplastic and autoimmune diseases; treatment of neurological disorders; for stimulating white blood cell production; for stimulating red blood cell production; and for increasing platelet count.
  1     2        Next Page